Concepedia

L. Weijers

LW

Statistics

Publications

2

Citations

21

H-Index

2

Active since

2017

Affiliations

Alnylam Pharmaceuticals (United States)(Current)

L. Weijers is an author at Alnylam Pharmaceuticals (United States) specializing in rheumatoid arthritis therapy, rheumatology, and pharmacotherapy.

ORCID

Publications per year

2017–2024

2

Publications

2

The journey to diagnosis of wild-type transthyretin-mediated (ATTRwt) amyloidosis: a path with multisystem involvement

Chafic Karam, Colleen Moffitt, Catherine Summers et al. · Orphanet Journal of Rare Diseases · 2024 · 11 citations · Full text

, , +13

Cost per response for abatacept versus adalimumab in rheumatoid arthritis by ACPA subgroups in Germany, Italy, Spain, US and Canada

L. Weijers, Christoph Baerwald, Francesco Saverio Mennini et al. · Rheumatology International · 2017 · 10 citations · Full text

, , +17

1–2 of 2